| The Treatment |
|
|
|
|
The itm Rhenium PTA/PTCA® is a local irradiation of arteries from inside (Endovascular Brachytherapy). Aim of the therapy is the prevention of restenosis in periphery or cardiology. The method is a supplementary treatment to a previous Percutaneous Transluminal Angioplasty (PTA). itm Rhenium-PTA® reduces the proliferation of cells in the treated area of the vessel, which is a common side-effect after conventional PTA. A renewed narrowing of the vessel is prevented.
|
News
8-530.c1 - New OPS-Code for itm Rhenium-PTA®Since 2009 the itm Rhenium PTA® has been successfully applied in the treatment of heavily sick patients (Fontaine stages II...Read more... |
Dierk Scheinert, MD, presents itm Rhenium-PTA® at TCT 2011 in San Francisco, CA, Nov 7, 2011Dierk Scheinert, MD, from Park-Krankenhaus Leipzig, presents the excellent clinical results of itm Rhenium-PTA® at TCT 2011 - Transcatheter Cardiovascular...Read more... |
Video about itm Rhenium-PTA® treatmentOver 100 patients with progressed stages (Fontaine Stage III and IV) of peripheral endovascular disease and unusually large lesions have...Read more... |





